Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Indexes of the erythropoietin level in the blood plasma of chronic heart failure patients with anemia.

Zahidova KK.

J Basic Clin Physiol Pharmacol. 2018 Jan 26;29(1):11-17. doi: 10.1515/jbcpp-2016-0102.

PMID:
29220885
2.

Efficacy and Long-Term Safety of C.E.R.A. Maintenance in Pediatric Hemodialysis Patients with Anemia of CKD.

Fischbach M, Wühl E, Reigner SCM, Morgan Z, Schaefer F.

Clin J Am Soc Nephrol. 2018 Jan 6;13(1):81-90. doi: 10.2215/CJN.03570417. Epub 2017 Nov 2. Erratum in: Clin J Am Soc Nephrol. 2019 Jun 7;14(6):907.

3.

Influence of Erythropoiesis-Stimulating Agents on HbA1c and Fructosamine in Patients with Haemodialysis.

Rasche FM, Ebert T, Beckmann J, Busch V, Barinka F, Rasche WG, Lindner TH, Schneider JG, Schiekofer S.

Exp Clin Endocrinol Diabetes. 2017 Jun;125(6):384-391. doi: 10.1055/s-0042-124577. Epub 2017 Apr 13.

PMID:
28407666
4.

Targets for adapting intravenous iron dose in hemodialysis: a proof of concept study.

Peters NO, Jay N, Cridlig J, Rostoker G, Frimat L.

BMC Nephrol. 2017 Mar 20;18(1):97. doi: 10.1186/s12882-017-0513-x.

5.

Effect of methoxy polyethylene glycol-epoetin beta on oxidative stress in predialysis patients with chronic kidney disease.

Bartnicki P, Fijałkowski P, Majczyk M, Błaszczyk J, Banach M, Rysz J.

Med Sci Monit. 2013 Nov 8;19:954-9. doi: 10.12659/MSM.884024.

6.

Hemoglobin maintenance and dosing strategies using intravenous continuous erythropoietin receptor activator in Japanese hemodialysis patients.

Hirai T, Nishizawa Y, Nakazono H, Asai M, Yamashita H, Sasaki A, Yamashita T, Yamashita K, Shigemoto K, Harada S, Mizuiri S.

Ther Apher Dial. 2013 Oct;17(5):498-503. doi: 10.1111/1744-9987.12013. Epub 2013 Feb 28.

PMID:
24107278
7.

[Opatija study: observation of hemodialysis patients and titration of CERA dose just switched from another erythropoiesis stimulating agent].

Jelić I, Lovcić V, Kurtović I, Josipović M, Havranek Z, Kostić L, Racki S.

Acta Med Croatica. 2012 Jul;66(3):157-64. Croatian.

PMID:
23441529
8.

Treatment of anemia with epoetin in kidney transplant recipients.

Bren A, Arnol M, Kandus A, Varl J, Oblak M, Lindič J, Pajek J, Knap B, Kovač D, Mlinšek G, Buturović-Ponikvar J.

Ther Apher Dial. 2011 Jun;15(3):257-60. doi: 10.1111/j.1744-9987.2011.00947.x.

PMID:
21624072
9.

Maintenance treatment of renal anaemia in haemodialysis patients with methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa administered monthly: a randomized comparative trial.

Carrera F, Lok CE, de Francisco A, Locatelli F, Mann JF, Canaud B, Kerr PG, Macdougall IC, Besarab A, Villa G, Kazes I, Van Vlem B, Jolly S, Beyer U, Dougherty FC; PATRONUS Investigators.

Nephrol Dial Transplant. 2010 Dec;25(12):4009-17. doi: 10.1093/ndt/gfq305. Epub 2010 Jun 3.

10.

Effects of CERA (continuous erythropoietin receptor activator) in patients with advanced non-small-cell lung cancer (NSCLC) receiving chemotherapy: results of a phase II study.

Gascon P, Pirker R, Del Mastro L, Durrwell L.

Ann Oncol. 2010 Oct;21(10):2029-39. doi: 10.1093/annonc/mdq073. Epub 2010 Mar 24.

PMID:
20335369
11.

Efficacy of intravenous methoxy polyethylene glycol-epoetin beta administered every 2 weeks compared with epoetin administered 3 times weekly in patients treated by hemodialysis or peritoneal dialysis: a randomized trial.

Klinger M, Arias M, Vargemezis V, Besarab A, Sulowicz W, Gerntholtz T, Ciechanowski K, Dougherty FC, Beyer U.

Am J Kidney Dis. 2007 Dec;50(6):989-1000.

PMID:
18037099
12.

Pharmacokinetic and pharmacodynamic properties of methoxy polyethylene glycol-epoetin beta are unaffected by the site of subcutaneous administration.

Fishbane S, Pannier A, Liogier X, Jordan P, Dougherty FC, Reigner B.

J Clin Pharmacol. 2007 Nov;47(11):1390-7.

PMID:
17962427
13.

Intravenous methoxy polyethylene glycol-epoetin beta for haemoglobin control in patients with chronic kidney disease who are on dialysis: a randomised non-inferiority trial (MAXIMA).

Levin NW, Fishbane S, Cañedo FV, Zeig S, Nassar GM, Moran JE, Villa G, Beyer U, Oguey D; MAXIMA study investigators.

Lancet. 2007 Oct 20;370(9596):1415-21. Erratum in: Lancet. 2008 Feb 2;371(9610):386.

PMID:
17950856

Supplemental Content

Loading ...
Support Center